Filing Details
- Accession Number:
- 0001179110-15-008098
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-19 16:47:38
- Reporting Period:
- 2015-05-15
- Filing Date:
- 2015-05-19
- Accepted Time:
- 2015-05-19 16:47:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1199632 | J William Bolt | C/O Abiomed, Inc. 22 Cherry Hill Drive Danvers MA 01923 | Svp, Qa And Regulatory Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 Par | Disposition | 2015-05-15 | 4,100 | $67.85 | 102,181 | No | 4 | S | Direct | |
| Common Stock, $.01 Par | Disposition | 2015-05-15 | 209 | $68.49 | 101,972 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock option (right to buy) | $13.80 | 2009-05-23 | 2018-05-23 | 0 | 9,666 | Direct |
| Common Stock | Stock Option (right to buy) | $10.03 | 2011-06-03 | 2020-06-03 | 0 | 25,000 | Direct |
| Common Stock | Stock Option (right to buy) | $22.44 | 2013-05-22 | 2022-05-22 | 0 | 20,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $23.15 | 2014-05-14 | 2023-05-14 | 0 | 20,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $21.55 | 2015-05-14 | 2024-05-14 | 0 | 15,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $66.25 | 2016-05-13 | 2025-05-13 | 0 | 6,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2018-05-23 | 0 | 9,666 | Direct |
| 2020-06-03 | 0 | 25,000 | Direct |
| 2022-05-22 | 0 | 20,000 | Direct |
| 2023-05-14 | 0 | 20,000 | Direct |
| 2024-05-14 | 0 | 15,000 | Direct |
| 2025-05-13 | 0 | 6,000 | Direct |
Footnotes
- These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of this option to buy the number of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- Sale of common stock pursuant to reporting owner's 10b5-1 plan, solely for payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $67.2700 and $68.1800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $68.3100 and $68.5000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Billionaire Hedge Funds
